Current therapeutic strategies and future perspectives for the treatment of venous thromboembolism.
Pulmonary embolism (PE) and deep vein thrombosis (DVT) are widely regarded as manifestations of a single disease, venous thromboembolism (VTE). An evidence-based approach to the treatment of acute VTE will be reviewed here. Currently available therapeutic options will be emphasized; possible future treatment approaches will be discussed briefly. The chronic management of VTE involves assessment of the risks and benefits of prolonged anticoagulation and is discussed in more detail elsewhere in this issue.
Garcia
David A
DA
University of New Mexico, Albuquerque, NM, USA. davgarcia@salud.unm.edu
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D015507:Drugs, Investigational / Q000627:therapeutic use*; D017128:Embolectomy / Q000379:methods; D057505:Embolic Protection Devices; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005544:Forecasting; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000628:therapy*
D000925:Anticoagulants; D015507:Drugs, Investigational; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D001241:Aspirin